Provide names of other journalists involved.
Mehmet Oz, Greg Tufaro, Kaci Lindhorst
List date(s) this work was published or aired.
3/27/2012
Provide a brief synopsis of the story or stories, including any significant findings.
We presented information about the recent FDA-approval of botulinum toxin type A (botox) for the treatment of chronic migraine
Explain types of documents, data or Internet resources used. Were FOI or public records act requests required? How did this affect the work?
Medical research and FDA press release
Explain types of human sources used.
Dr. Nampiaparampil synthesized and explained the medical research.
Results:
Botox is a safe and effective strategy for treating people with chronic refractory migraine
Follow-up (if any). Have you run a correction or clarification on the report or has anyone come forward to challenge its accuracy? If so, please explain.
There have been no disputes.
Advice to other journalists planning a similar story or project.
Consider demonstrating the use of a pharmaceutical product to engage the audience.